mortality/aging
• mice show mortality similar to other reported Fgf23-deficient mice
|
growth/size/body
• body weight is significantly lower at 2 weeks of age; there is no significant change between 2 and 6 weeks indicating growth arrest
|
• at 2 weeks of age, body length is significantly lower than wild-type; there is no significant change between 2 and 6 weeks indicating growth arrest
|
homeostasis/metabolism
• levels are decreased by ~50% in homozygotes compared to wild-type
|
• serum calcium is slightly increased compared to wild-type
|
• levels are significantly higher than in wild-type
|
• male mice show an ~2-fold increase in serum 1,25(OH)2D3 concentrations compared to wild-type
|
skeleton
• mice display a dyschondroplasia leading to impaired long bone growth
|
short femur
(
J:110579
)
• there is an increase in this zone relative to the proliferative zone without appreciable widening of the growth plate
|
• bones show increased calcification of the subchondral region of the distal methaphysis
|
• mice have miniaturized bones of normal shape
|
• there is a ~20% decrease in bone mineral density
|
• there is a reduction in trabecular bone volume
|
• mice display reduced osteoid volume and impaired mineralization
|
limbs/digits/tail
short femur
(
J:110579
)